investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Discovery of New Targets and Pathways for T-ALL Therapy
A. Thomas Look
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
A. Thomas Look
Dana-Farber Cancer Institute
Boston, United States
Related projects
Oliver W. Press
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
Leukaemia
Wilburn E. Reddick
ALL therapy and developing brains: MRI measures, genetic factors and cognition
Leukaemia
Pediatric oncology or childhood cancer
Pier Paolo Pandolfi
Targeting Tumor Suppressive Pathways for Cancer Therapy
Leukaemia
Christopher S Carlson
Impact of primary tumor development stage on prognosis and outcome in B-ALL
Leukaemia
Pediatric oncology or childhood cancer
Aude Chapuis
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
Leukaemia
Alejandro Gutierrez
Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
Leukaemia
Martha Lassiter
Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital
Leukaemia
Richard John O'Reilly
Immunobiology for Marrow Allografts for Leukemia
Leukaemia
Stanley R. Riddell
Targeted therapy of B cell malignances with CAR-T cells of defined composition
Leukaemia